
يتطور
Business·22.04.2026ملخص الذكاء الاصطناعي
China's Volume-Based Drug Procurement Policy Creates Two-Tier Market
China's volume-based procurement policy forces multinational drug companies to lower prices for public hospital purchases while allowing biotech firms to charge premium prices in the private market. The dual-track system benefits internet healthcare platforms and private healthcare providers like Alibaba Health, Yifeng and Hygeia, according to Citi research.
S
SCMP Economy